G1 THERAPEUTICS INC. - COMMON STOCK

G1 Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 1, 2023

18 أكتوبر 2023 07:30:06 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium

16 أكتوبر 2023 09:00:33 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

05 سبتمبر 2023 11:00:29 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 سبتمبر 2023 16:15:21 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights

02 أغسطس 2023 06:30:27 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in Two August Investor Conferences

31 يوليو 2023 14:30:27 بحسب Nasdaq GlobeNewswire

New Publication Highlights Real World Impact of Trilaciclib on Myelosuppressive Events in Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

31 يوليو 2023 08:30:40 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Release Second Quarter 2023 Financial Results and Provide Business Update on August 2, 2023

26 يوليو 2023 09:00:31 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 يوليو 2023 16:15:03 بحسب Nasdaq GlobeNewswire

Trilaciclib Increases Pool of Memory T Cells in the Tumor Microenvironment Responsible for Long Term Immune Surveillance and Efficacy

04 يونيو 2023 07:13:44 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 يونيو 2023 16:40:59 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel

22 مايو 2023 16:45:22 بحسب Nasdaq GlobeNewswire

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer

16 مايو 2023 07:30:11 بحسب Nasdaq GlobeNewswire

New Results from Phase 2 Trial Confirm Benefit of Trilaciclib in Reducing Adverse Events Related to an Antibody Drug Conjugate (ADC)

10 مايو 2023 07:31:04 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights

03 مايو 2023 06:30:55 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 مايو 2023 17:00:50 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023

26 أبريل 2023 12:45:27 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference

11 أبريل 2023 12:30:49 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

01 مارس 2023 06:30:27 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

28 فبراير 2023 14:10:49 بحسب Nasdaq GlobeNewswire